196 related articles for article (PubMed ID: 3885861)
1. [Antitumor effect of OK-432 (3)--mechanisms of tumor growth inhibition by OK-432 induced activated macrophages].
Nanjo M; Saito M; Aonuma E; Fujimura H; Nakamura T; Aso H; Yoshie O; Ebina T; Ishida N
Gan To Kagaku Ryoho; 1985 Apr; 12(4):887-93. PubMed ID: 3885861
[TBL] [Abstract][Full Text] [Related]
2. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
Saito M; Aonuma E; Noda T; Nakadate I; Nanjo M; Ebina T; Ishida N
Gan To Kagaku Ryoho; 1983 May; 10(5):1363-71. PubMed ID: 6870302
[TBL] [Abstract][Full Text] [Related]
3. In vivo antitumor effect of lymphokine-activated rodent polymorphonuclear leukocytes.
Fujii Y; Kimura S; Arai S; Sendo F
Cancer Res; 1987 Nov; 47(22):6000-5. PubMed ID: 3117360
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor effect of a novel antitumor compound, NC-190, in the double grafted tumor system].
Ebina T; Shishido K; Murata K
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1345-50. PubMed ID: 2369138
[TBL] [Abstract][Full Text] [Related]
5. [Antitumor effect of Cepharanthin in the double grafted tumor system].
Ebina T; Ishikawa K; Murata K
Gan To Kagaku Ryoho; 1990 Jun; 17(6):1165-71. PubMed ID: 2350192
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)].
Saito M; Yamaguchi T; Aonuma E; Noda T; Edina T; Ishida N
Gan To Kagaku Ryoho; 1982 Nov; 9(11):2031-7. PubMed ID: 6820888
[TBL] [Abstract][Full Text] [Related]
7. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
Mizushima Y; Morikage T; Hirata H; Sato M; Sakamoto K; Yano S
J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor efficacy of activated macrophages against murine glioma cells].
Miyao Y; Shimizu K; Okamoto Y; Matsui Y; Ushio Y; Hayakawa T; Tsuda N; Mogami H
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2082-8. PubMed ID: 3717955
[TBL] [Abstract][Full Text] [Related]
9. Augmentation by OK-432 of generation of culture-induced killer cells.
Ujiie T
Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
[TBL] [Abstract][Full Text] [Related]
10. Activated macrophages are responsible for the tumor-inhibitory effect in mice receiving intravenous injection of OK-432.
Saito M; Nanjo M; Aonuma E; Noda T; Nakadate I; Ebina T; Ishida N
Int J Cancer; 1984 Feb; 33(2):271-6. PubMed ID: 6420351
[TBL] [Abstract][Full Text] [Related]
11. [Role of the spleen in OK-432 immunotherapy and characterization of effector cells].
Yamagishi H; Naito K; Maeda Y; Kobayashi M; Kurioka H; Fujimori C; Tanaka T; Hashimoto I
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1670-8. PubMed ID: 6870309
[TBL] [Abstract][Full Text] [Related]
12. [Induction of LAK cells in peritoneal cavity of mice after ip injection of OK-432 and antitumor effect of these LAK cells].
Ishida N; Saito M; Nanjo M
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2681-90. PubMed ID: 6508321
[TBL] [Abstract][Full Text] [Related]
13. Antitumor mechanisms of Z-100, an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis: the importance of lymphocytes infiltrated into tumor sites.
Sasaki H; Schmitt D; Hayashi Y; Pollard RB; Suzuki F
Nat Immun; 1993; 12(2):104-12. PubMed ID: 8318815
[TBL] [Abstract][Full Text] [Related]
14. [Differences in the immunostimulatory activity and antitumor therapeutic effect of OK-432 and N-CWS].
Mizushima Y; Iwata M; Sato M; Hirata H; Takashima A; Yano S
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2404-10. PubMed ID: 3729493
[TBL] [Abstract][Full Text] [Related]
15. [Immunobiological studies of interferon-alpha A/D in comparison with a streptococcal preparation, OK-432].
Mizushima Y; Hirata H; Sakamoto K; Sato M; Morikage T; Maruyama M; Sasaki K; Yano S
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2710-5. PubMed ID: 3631971
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of tumoricidal activity of OK-432-specific L3T4+ Lyt2- T-cells.
Ozaki S; Suginoshita T; Watanabe T; Obayashi H
Cancer Res; 1990 Aug; 50(15):4630-4. PubMed ID: 2369739
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). I. Sequential effector mechanisms following a single OK-432 injection in F344 rats leading to the rejection of syngeneic MADB106 tumor cells.
Fukui H; Reynolds CW
J Natl Cancer Inst; 1987 Nov; 79(5):1011-7. PubMed ID: 3479632
[TBL] [Abstract][Full Text] [Related]
18. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
Ujiie T
Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). II. Analysis of the cytotoxic lymphocytes induced by OK-432 injection into tumor-bearing F344 rats.
Fukui H; Reynolds CW
J Natl Cancer Inst; 1987 Nov; 79(5):1019-24. PubMed ID: 3500354
[TBL] [Abstract][Full Text] [Related]
20. Studies of the immune response against a polyoma virus-induced fibrosarcoma in BALB mice using the Winn's tumor neutralization assay.
de Lapeyrière O; Imbert J; Cot E; Meyer G
Bull Cancer; 1981; 68(2):101-8. PubMed ID: 6263382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]